Recent research utilizing Csf2rb-/- PAP mice has demonstrated that pioglitazone can increase the expression of ABCG1, enhance cholesterol efflux in AMs, and alleviate pulmonary symptoms in PAP mice (135). Here, ABCG1 is linked to pulmonary alveolar proteinosis.